CD8A and ovarian neoplasm: Here, we developed targeted deletion mutants using genetically tractable Δku80 uracil auxotrophic vaccine strains to explore the extent to which parasite secreted ROP and GRA effector proteins are associated with mechanisms that promote CD8+ T cell dependent therapeutic immunity to established highly aggressive ovarian tumors [16,90].